Victor Manuel García Nieto

Prof. Victor Manuel García Nieto


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2015 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ACAlejandro García Castaño
Alejandro García Castaño
RGRenalTube Group
RenalTube Group
GNGustavo Pérez de Nanclares
Gustavo Pérez de Nanclares
LMLeire Madariaga
Leire Madariaga
MAMireia Aguirre
Mireia Aguirre
GAGema Ariceta
Gema Ariceta

1 March 2005 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
MWMatthias T. F. Wolf
Matthias T. F. Wolf
IZIsabella Zalewski
Isabella Zalewski
FCFelix Claverie-Martin
Felix Claverie-Martin
RRRainer Ruf
Rainer Ruf
DMDominik Muller
Dominik Muller
FHFriedhelm Hildebrandt
Friedhelm Hildebrandt
Background. Nephrolithiasis is a complex, multifactorial disease resulting from genetic and environmental interaction. The pathogenesis of nephrolithiasis is far from being understood. So far, no gene locus for autosomal dominant nephrolithiasis only has been described. We here identified a new suggestive gene locus for autosomal dominant nephrolithiasis by a genome-wide search for linkage in a Spanish kindred with nephrolithiasis. Methods. Clinical data, blood and urine samples of 18 individuals from a Spanish kindred with nephrolithiasis were collected. We performed a genome-wide search for linkage using 380 polymorphic microsatellite markers. Results. Nephrolithiasis segregated in this Spanish kindred in a pattern compatible with autosomal dominant inheritance. The total genome search yielded the highest two-point LOD score of Zmax = 1.99 (𝛉 = 0) for marker D9S159 on chromosome 9q33.2–q34.2. Multipoint analysis of 24 polymorphic markers used for further fine mapping resulted in a LOD score of Zmax = 2.7 (𝛉 = 0) for markers D9S1881–D9S164, thereby identifiying a new gene locus for autosomal dominant nephrolithiasis (NPL1). Two recombination events define D9S1850 as the centromeric flanking marker and D9S1818 as the telomeric flanking marker, restricting the NPL1 locus to a 14 Mb interval. Conclusion. We here identified a new suggestive gene locus (NPL1) for autosomal dominant nephrolithiasis. It is localized on chromosome 9q33.2–q34.2. The identification of the responsible gene will provide new insights into the molecular basis of nephrolithiasis.

31 January 2019 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
VNVictor Manuel García Nieto
Victor Manuel García Nieto
VGVictoria E. García-Rodríguez
Victoria E. García-Rodríguez
MLMaría Isabel Luis-Yanes
María Isabel Luis-Yanes
MMMargarita Monge
Margarita Monge
PAPedro Arango-Sancho
Pedro Arango-Sancho
EGEduardo H. Garin
Eduardo H. Garin

1 November 2019 in Nefrología
Verified
Journal Article
Open access
VNVictor Manuel García Nieto
Victor Manuel García Nieto
MYMaría Isabel Luis Yanes
María Isabel Luis Yanes
PCPatricia Tejera Carreño
Patricia Tejera Carreño
GSGerman Perez Suarez
German Perez Suarez
TMTeresa Moraleda Mesa
Teresa Moraleda Mesa
Idiopathic hypercalciuria (IH) is defined as that clinical situation in which an increase in urinary calcium excretion is observed, in the absence of hypercalcemia and other known causes of hypercalciuria. In recent years, its diagnosis in pediatric age has been more frequent because it has been known that it can debut with very different symptoms, in the absence of kidney stone formation. The discovery of genetic hypercalciuric stone-forming rats has allowed us to glimpse the pathophysiological mechanism of IH since they show many data in common with humans with IH as normal levels of blood calcium, intestinal calcium hyperabsorption, increased bone resorption and a defect in the renal tubular calcium reabsorption. In 1993, it was shown that in these animals there is an increase in the number of vitamin D receptors (VDR) in the intestine, which favors an increase in the functional capacity of calcitriol-VDR complexes that explains the increase in intestinal transport of calcium. The same happens at the bone level producing a greater resorption. In our opinion, IH is a 'metabolic anomaly' or, better, an inheritable constitutive metabolic characteristic. In this sense, what patients with IH would inherit is the availability of having a greater number of VDRs in their cells than those with normal urinary calcium excretion. IH cannot be considered a sensu stricto disease, so pharmacological treatment must be individualized.

11 December 2007 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
VNVictor Manuel García Nieto
Victor Manuel García Nieto
MYMaría Isabel Luis Yanes
María Isabel Luis Yanes
MZMargarita Monge Zamorano
Margarita Monge Zamorano
MGMa José Hernández González
Ma José Hernández González
CACarolina Peralta Aros
Carolina Peralta Aros
EGEduardo H Garin
Eduardo H Garin

Verified
Journal Article
Open access
PDF file
APAna Perdomo-Ramirez
Ana Perdomo-Ramirez
ECELIZABETH CORDOBA-LANUS
ELIZABETH CORDOBA-LANUS
CTCarmen Jane Trujillo-Frias
Carmen Jane Trujillo-Frias
CGCarolina Gonzalez-Navasa
Carolina Gonzalez-Navasa
ERElena Ramos-Trujillo
Elena Ramos-Trujillo
FCFelix Claverie-Martin
Felix Claverie-Martin
Renal hypouricemia (RHUC) is a rare inherited disorder characterized by impaired urate reabsorption in the proximal tubule resulting in low urate serum levels and increased urate excretion. Some patients may present severe complications such as exercise-induced acute renal failure and nephrolithiasis. RHUC is caused by inactivating mutations in the SLC22A12 (RHUC type 1) or SLC2A9 (RHUC type 2) genes, which encode urate transporters URAT1 and GLUT9, respectively. In this study, our goal was to identify mutations associated with twenty-one new cases with RHUC through direct sequencing of SLC22A12 and SLC2A9 coding exons. Additionally, we carried out an SNPs-haplotype analysis to determine whether the rare SLC2A9 variant c.374C>T; p.(T125M), which is recurrent in Spanish families with RHUC type 2, had a common-linked haplotype. Six intragenic informative SNPs were analyzed using PCR amplification from genomic DNA and direct sequencing. Our results showed that ten patients carried the SLC22A12 mutation c.1400C>T; p.(T467M), ten presented the SLC2A9 mutation c.374C>T, and one carried a new SLC2A9 heterozygous mutation, c.593G>A; p.(R198H). Patients carrying the SLC2A9 mutation c.374C>T share a common-linked haplotype, confirming that it emerged due to a founder effect.